Aida Pharmaceuticals, Inc.
AIDA · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8 | $6 | $3 | – |
| Short-Term Investments | $11 | $0 | $0 | – |
| Receivables | $11 | $17 | $14 | – |
| Inventory | $4 | $3 | $3 | – |
| Other Curr. Assets | $1 | $3 | $2 | – |
| Total Curr. Assets | $36 | $29 | $22 | – |
| Property Plant & Equip (Net) | $17 | $14 | $13 | – |
| Goodwill | $0 | $0 | $0 | – |
| Intangibles | $9 | $9 | $4 | – |
| Long-Term Investments | $0 | $0 | $0 | – |
| Tax Assets | $0 | $0 | $0 | – |
| Other NC Assets | $0 | $1 | $4 | – |
| Total NC Assets | $26 | $25 | $20 | – |
| Other Assets | $0 | $0 | $0 | – |
| Total Assets | $63 | $54 | $43 | – |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | – |
| Short-Term Debt | $32 | $28 | $21 | – |
| Tax Payable | $0 | $0 | $0 | – |
| Deferred Revenue | $0 | $0 | $0 | – |
| Other Curr. Liab. | $4 | $3 | $5 | – |
| Total Curr. Liab. | $39 | $34 | $28 | – |
| LT Debt | $2 | $6 | $4 | – |
| Deferred Rev, NC | $0 | $0 | $0 | – |
| Deferred Tax Liab, NC | $1 | $1 | $0 | – |
| Other NC Liab. | $0 | -$3 | $0 | – |
| Total NC Liab. | $3 | $4 | $4 | – |
| Other Liabilities | $0 | $0 | $0 | – |
| Cap. Leases | $0 | $0 | $0 | – |
| Total Liabilities | $42 | $38 | $32 | – |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | – |
| Common Stock | $0 | $0 | $0 | – |
| Retained Earnings | $7 | $5 | $3 | – |
| AOCI | $1 | $1 | $0 | – |
| Other Equity | $5 | $5 | $3 | – |
| Total Equity | $13 | $10 | $7 | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | $8 | $5 | $4 | – |
| Total Liab. & Tot. Equity | $63 | $54 | $43 | – |
| Net Debt | $25 | $27 | $22 | $0 |